Infographics and videos
About Gut Microbiota

Digestive health goes beyond digestion. This overview revisits the gastrointestinal system, including how it functions, the role of the gut microbiota, and its connections with other organs in shaping overall health.

From diet to microbiome therapies: Key insights from the GMFH Summit 2026

19 May 2026

by Manon Oliero, Giovana Martucelli, Andreu Prados

The 14th edition of the Gut Microbiota for Health World Summit brought together leading researchers from around the world to present the latest advances in the field. The meeting reinforced clinical practices that have become increasingly established in recent years and also presented unpublished results on new microbiome-targeted therapies, in line with the summit’s central theme: “Diet and other ways to manipulate the gut microbiome in clinical practice.”

The gluten-free diet for celiac disease can be low in fiber. Researchers from McMaster University showed that people with celiac disease had reduced capacity to metabolize dietary fiber in the small intestine because they lack key fiber-degrading bacteria.

Stay tuned to our latest news

by subscribing to our newsletters

Check our latest issues

Food 4 Gut Health news

Digestive symptoms with an impact on quality of life (QoL) affect one in four adults in the general population worldwide who do not qualify for a diagnosis of a Disorder of Gut-Brain Interaction (DGBI). Recent research suggests this ‘sub-diagnostic’ group demands additional investigation and might benefit from targeted interventions, including dietary interventions.

Dietary fiber is often seen as essential for gut health. However, is it always beneficial? New research challenges this idea, highlighting that not all fibers act the same and that context, type, and dose matter.

GMFH Summit past editions
Research & Practice

Research & Practice news

While diet is a major determinant of the human gut microbiome, little is known about diet-microbiome associations at species-level resolution. New findings from the Human Phenotype Project found species-level, food-specific associations validated at population scale that might guide personalized nutrition.

Digestive symptoms with an impact on quality of life (QoL) affect one in four adults in the general population worldwide who do not qualify for a diagnosis of a Disorder of Gut-Brain Interaction (DGBI). Recent research suggests this ‘sub-diagnostic’ group demands additional investigation and might benefit from targeted interventions, including dietary interventions.

The European regulatory landscape for microbiome-based therapies is rapidly evolving. New frameworks like the SoHO Regulation aim to harmonize safety, quality, and access across countries. This article explores the current challenges, opportunities, and expert perspectives shaping the field.